-
1
-
-
0344207463
-
Safety issues in drug therapy of the diabetic patient
-
Krentz AJ, ed. Auckland: Adis Books
-
Gilbert R, Cooper M, Krum H. Safety issues in drug therapy of the diabetic patient. In: Krentz AJ, ed. Drug treatment of type 2 diabetes. Auckland: Adis Books, 2000: 45-60.
-
(2000)
Drug Treatment of Type 2 Diabetes
, pp. 45-60
-
-
Gilbert, R.1
Cooper, M.2
Krum, H.3
-
2
-
-
0033157113
-
Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: A review
-
Burge MR, Sood V, Sobhy TA, et al. Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review. Diabetes Obesity & Metabolism 1999;1:199-206.
-
(1999)
Diabetes Obesity & Metabolism
, vol.1
, pp. 199-206
-
-
Burge, M.R.1
Sood, V.2
Sobhy, T.A.3
-
3
-
-
0004223602
-
-
London: British Medical Association and Royal Pharmaceutical Society of Great Britain, September
-
Kendall MJ, ed. British national formulary. 44th Ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, September 2002.
-
(2002)
British National Formulary. 44th Ed.
-
-
Kendall, M.J.1
-
4
-
-
0023350882
-
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs
-
Femer RE, Chaplin S. The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. Clin Pharmacokinet 1987;12:379-401.
-
(1987)
Clin Pharmacokinet
, vol.12
, pp. 379-401
-
-
Femer, R.E.1
Chaplin, S.2
-
5
-
-
0022972005
-
Dangerous misuse of sulphonylureas
-
Ludman P, Mason P, Joplin GF. Dangerous misuse of sulphonylureas. BMJ 1986;293:1287-8.
-
(1986)
BMJ
, vol.293
, pp. 1287-1288
-
-
Ludman, P.1
Mason, P.2
Joplin, G.F.3
-
6
-
-
0017649629
-
Chlorpropamide-induced hypoglycemia: Successful treatment with diazoxide
-
Johnson SF, Schade DS, Peake GT. Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide. Am J Med 1977;63:799-804.
-
(1977)
Am J Med
, vol.63
, pp. 799-804
-
-
Johnson, S.F.1
Schade, D.S.2
Peake, G.T.3
-
7
-
-
0025990636
-
Clinical spectrum of sulfonylurea overdose and experience with diozoxide therapy
-
Palatnick W, Meatherall RC, Tenenbein M. Clinical spectrum of sulfonylurea overdose and experience with diozoxide therapy. Arch Intern Med 1991;151:1859-62.
-
(1991)
Arch Intern Med
, vol.151
, pp. 1859-1862
-
-
Palatnick, W.1
Meatherall, R.C.2
Tenenbein, M.3
-
8
-
-
0027457178
-
Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses
-
Boyle PJ, Justice K, Krentz AJ, et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 1993;76:752-6.
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 752-756
-
-
Boyle, P.J.1
Justice, K.2
Krentz, A.J.3
-
9
-
-
0027470453
-
Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide
-
Krentz AJ, Boyle PJ, Justice KM, et al. Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide. Diabetes Care 1993;16:184-6.
-
(1993)
Diabetes Care
, vol.16
, pp. 184-186
-
-
Krentz, A.J.1
Boyle, P.J.2
Justice, K.M.3
-
11
-
-
0030916462
-
Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes
-
Braatvedt GD. Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes. N Z Med J 1997;110:189-90.
-
(1997)
N Z Med J
, vol.110
, pp. 189-190
-
-
Braatvedt, G.D.1
-
12
-
-
0031021488
-
Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia
-
Graudins A, Linden CH, Ferm RP. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia. Am J Emerg Med 1997;15:95-6.
-
(1997)
Am J Emerg Med
, vol.15
, pp. 95-96
-
-
Graudins, A.1
Linden, C.H.2
Ferm, R.P.3
|